Alseres Pharmaceuticals, Inc. Stock Other OTC
Equities
ALSE
US0211522026
Pharmaceuticals
Sales 2012 | 0.53 0.73 | Sales 2013 | 0.47 0.65 | Capitalization | 720K 991K |
---|---|---|---|---|---|
Net income 2012 | -1M -1.38M | Net income 2013 | - 0 | EV / Sales 2012 | 15,697,473 x |
Net Debt 2012 | 5.88M 8.09M | Net Debt 2013 | 8.01M 11.02M | EV / Sales 2013 | 18,426,686 x |
P/E ratio 2012 * |
-
| P/E ratio 2013 |
-
| Employees | - |
Yield 2012 * |
-
| Yield 2013 |
-
| Free-Float | 33.8% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Savas
CEO | Chief Executive Officer | 75 | 04-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Savas
CEO | Chief Executive Officer | 75 | 04-08-31 |
1st Jan change | Capi. | |
---|---|---|
-27.79% | 1.48B | |
-18.38% | 57.39M |